Buy 5 or More Products! Save 25% On Total.
 Buy 3 or More Products! Save 10% On Total.
 Free Shipping! No Minimum Order.



Blog Empty Image

Minnesota Pharmacies Could Take Back Prescription Medicines Under Proposed Legislation.


Minnesota Pharmacies Could Take Back Prescription Medicines Under Proposed Legislation.

Pharmacies in Minnesota would be able to collect and dispose of controlled substances (CS) and non-CS under a proposed bill (Senate File (SF) 1425). Currently, it is unlawful for Minnesota pharmacies to take back prescription drugs, reports American Pharmacists Association. The companion bill to SF 1425 is House File 1503. To date, the proposed bill was referred to the Committee on Health, Human Services and Housing for a second reading.


Blog Empty Image

Sign or Sticker to Be Developed for Washington Pharmacies That Prescribe and Dispense Contraceptives.


Sign or Sticker to Be Developed for Washington Pharmacies That Prescribe and Dispense Contraceptives.

Once available from the Washington Pharmacy Quality Assurance Commission, a sticker or sign may be displayed at Washington pharmacies if their pharmacists are authorized to prescribe and dispense contraceptives under a collaborative drug therapy agreement. The plan aims to increase awareness of the availability of contraceptives in pharmacies. Under House Bill 2681, which was signed into law by Washington Governor Jay Inslee, the Pharmacy Quality Assurance Commission will develop a sticker or sign to be displayed at a pharmacy that initiates or modifies drug therapy related to self-administered contraception. The law goes into effect on June 9, 2016.


Blog Empty Image

Florida Law Restricts Sale of Dextromethorphan to Adults.


Florida Law Restricts Sale of Dextromethorphan to Adults.

A bill that prohibits a manufacturer, distributor, or retailer from selling a dextromethorphan product to a person younger than 18 years of age was signed into law by Florida Governor Rick Scott. An employee who sells a dextromethorphan product to a person younger than 18 years of age without a prescription is subject to a written warning for an initial violation, and civil fines may be imposed for subsequent violations. Under the law (Senate Bill 938), proof of age is required from the purchaser if the individual is presumed to be under 25 years of age. The law takes effect January 1, 2017.


Certain Utah Pharmacies to Offer Naloxone Under Collaborative Practice Agreement.


Certain Utah Pharmacies to Offer Naloxone Under Collaborative Practice Agreement.

Naloxone, the opioid overdose reversal drug, is available at Associated Food Stores retailer’s pharmacies in Utah under a collaborative pharmacy practice agreement with prescribers. Further, each pharmacist has been trained to provide patient counseling on the drug, indicates the company. A list of participating pharmacies is available in the Associated Food Stores press release. Patients under the age of 18 are required to bring an adult family member, notes Deseret News. The price of a kit ranges from $50 to $70, but patients who have insurance can get some of the cost covered, indicates Deseret News.
 
The state’s collaborative pharmacy practice agreement is defined under Senate Bill 158. Further information about dispensing naloxone in Utah is available in House Bill 119.


Blog Empty Image

HHS Proposes Increasing Buprenorphine Patient Limit for Medication-Assisted Treatment.


HHS Proposes Increasing Buprenorphine Patient Limit for Medication-Assisted Treatment.

With the goal of expanding access to medication-assisted treatment (MAT), United States Department of Health and Human Services (HHS) has proposed a rule that would permit qualified physicians to prescribe buprenorphine, the opioid use disorder treatment medication, to as many as 200 patients. Under current regulations, physicians who are certified to prescribe buprenorphine for MAT can only prescribe up to 30 patients initially and after one year can request authorization to prescribe up to a maximum of 100 patients. Substance Abuse and Mental Health Services Administration Principal Deputy Administrator Kana Enomoto states “there are long patient waiting lists for prescribers who have reached the 100 patient limit.”
 
Buprenorphine is a Food and Drug Administration (FDA)-approved drug used as part of MAT, a comprehensive way to address the recovery needs of individuals that combines the use of medication with counseling and behavioral therapies to treat substance use disorders, indicates the HHS press release. HHS Secretary Sylvia Burwell said the proposal “is critical in our comprehensive approach to addressing the serious opioid epidemic facing our nation.” More information about MAT and increasing the patient limit is available in the HHS fact sheet.
 
Written or electronic comments on the proposed rule must be submitted by May 31, 2016. The Federal Register notice contains instructions and additional information for submitting public comment.
 
www.pharmacyexam.com


Blog Empty Image

Pharmacists in Florida May Dispense Opioid Antagonist Pursuant to Standing Order.


Pharmacists in Florida May Dispense Opioid Antagonist Pursuant to Standing Order.

Pharmacists in Florida may dispense an emergency opioid antagonist pursuant to a non-patient-specific standing order prescribed by a health care provider, according to a recently passed law that goes into effect on July 1, 2016. The standing order would be for an auto-injection delivery system or intranasal application delivery system, which must be appropriately labeled with instructions for use, indicates the law (House Bill 1241).


Blog Empty Image

Idaho Bill Seeks to Lower Age for Children to Be Immunized by Pharmacists.


Idaho Bill Seeks to Lower Age for Children to Be Immunized by Pharmacists.
 
Pharmacists in Idaho would be able to prescribe and administer immunizations to children who are six years of age or older, under proposed legislation passed in the Idaho House of Representatives. Current Idaho law authorizes pharmacists to prescribe and administer immunizations to persons age 12 and older. Senate Bill 1294 has been reported as delivered to Governor Butch Otter.
 


Blog Empty Image

Pharmacists in Indiana are allowed denying the sale of ephedrine or pseudoephedrine products.

True or False


Pharmacists in Indiana are allowed denying the sale of ephedrine or pseudoephedrine products.

True or False

Answer: True. Pharmacists in Indiana may refuse to sell ephedrine or pseudoephedrine to a purchaser if the pharmacist determines that the drugs are not medically necessary, according to a recently passed law that goes into effect July 1, 2016. The pharmacist is provided with civil immunity for denying the sale, under Senate Bill 80 (SB 80).
 
The law states an individual who has a relationship on record with a pharmacy may purchase pseudoephedrine or ephedrine. However, if the purchaser does not have a relationship on record with the pharmacy, the pharmacist is required to determine whether there is a legitimate medical or pharmaceutical need for the ephedrine or pseudoephedrine.
 
A person who is denied the sale of a pseudoephedrine or ephedrine product may obtain pseudoephedrine or ephedrine pursuant to a prescription. SB 80 also adds ephedrine and pseudoephedrine to the definition of “controlled substance” for purposes of the Indiana Scheduled Prescription Electronic Collection and Tracking program. The Indiana Board of Pharmacy is required to adopt emergency rules that are effective July 1, 2016, under the bill.


Blog Empty Image

Which of the following best describes the Capitation System?
 
a. Risk free income for healthcare service providers.
b. Healthcare provider may get more incentive to provide an extended treatment to a patient.
c. A fixed amount of money per patient per unit of time paid in advance to the physician for the delivery of health care services.
d. A patient gets more benefit if he/she gets services from Healthcare provider receiving reimbursement through capitation.
e. Free prescription benefits to patients.



Which of the following best describes the Capitation System?
 
a. Risk free income for healthcare service providers.
b. Healthcare provider may get more incentive to provide an extended treatment to a patient.
c. A fixed amount of money per patient per unit of time paid in advance to the physician for the delivery of health care services.
d. A patient gets more benefit if he/she gets services from Healthcare provider receiving reimbursement through capitation.
e. Free prescription benefits to patients.

Answer: Capitation payments are used by managed care organizations to control health care costs. Capitation payments control use of health care resources by putting the physician at financial risk for services provided to patients. At the same time, in order to ensure that patients do not receive suboptimal care through under-utilization of health care services, managed care organizations measure rates of resource utilization in physician practices. These reports are made available to the public as a measure of health care quality, and can be linked to financial rewards, such as bonuses.
 
Capitation is a fixed amount of money per patient per unit of time paid in advance to the physician for the delivery of health care services. The actual amount of money paid is determined by the ranges of services that are provided, the number of patients involved, and the period of time during which the services are provided. Capitation rates are developed using local costs and average utilization of services and therefore can vary from one region of the country to another. In many plans, a risk pool is established as a percentage of the capitation payment. Money in this risk pool is withheld from the physician until the end of the fiscal year. If the health plan does well financially, the money is paid to the physician; if the health plan does poorly, the money is kept to pay the deficit expenses.
 
When the primary care provider signs a capitation agreement, a list of specific services that must be provided to patients is included in the contract. The amount of the capitation will be determined in part by the number of services provided and will vary from health plan to health plan, but most capitation payment plans for primary care services include the following:
 
·         Preventive, diagnostic, and treatment services
·         Injections, immunizations, and medications administered in the office
·         Outpatient laboratory tests done either in the office or at a designated laboratory
·         Health education and counseling services performed in the office
·         Routine vision and hearing screening




Free USA Shipping! No Minimum Order.
Free International Shipping! Over $350 or More.